MYOVANT SYMPOSIUM AT SEUD CONGRESS

WELCOME!

Dear Colleagues,
Good afternoon! I am delighted to welcome you to this educational satellite symposium entitled: NEW PERSPECTIVES IN UTERINE FIBROIDS. This timely, scientific event has been funded and organised by Myovant Sciences, GmbH.
Well, it has been a strange and challenging year for us all! While I am sorry we couldn’t meet face to face in Stockholm, thanks to modern technology and some improvisation, it is great to be able to still communicate and share some important information about uterine fibroids, together here.
I am honoured to Chair this symposium and be joined by Professor Erica Marsh and Professor Ayman Al-Hendy.
So, why do we need new perspectives in uterine fibroids? Well, as you will see from the agenda, it really is time to challenge the stigma and misperceptions surrounding these aspects of female health. We also need to be much more patient centred in how we manage this troublesome disease – which will include exploring new treatment perspectives too.
Specifically, the main learning objectives of this symposium are to:● Understand the stigma and taboo that still surround these aspects of female health● Identify the common disconnect between patients and healthcare professionals● Learn how we can all become much more patient centric● Understand the estrogen-driven basis of uterine fibroids● Review different therapeutic approaches to the management of uterine fibroids – including GnRH antagonists being developed
On behalf of the faculty, I’d like to welcome you to this symposium and hope we can all discover some new perspectives in uterine fibroids.
Professor Kristina Gemzell-DanielssonSymposium Chair

New Perspectives in Uterine Fibroids
    • Time

    • Presentation Title

    • Presenter

    • Time

    • Time

    • Presentation Title

    • Presentation Title

    • Presenter

    • Presenter

    • 13:40 – 13:45

    • Welcome and Introduction - The 21st Century Perspective

    • Prof. Kristina Gemzell-Danielsson(Karolinska Institutet, Stockholm, SE)

    • Time

    • 13:40 – 13:45

    • Presentation Title

    • Welcome and Introduction - The 21st Century Perspective

    • Presenter

    • Prof. Kristina Gemzell-Danielsson(Karolinska Institutet, Stockholm, SE)

    • 13:45 – 14:00

    • “Nothing About Me Without Me”:The Patient Perspective

    • Prof. Erica Marsh(University of Michigan, Ann Arbor, MI, USA)

    • Time

    • 13:45 – 14:00

    • Presentation Title

    • “Nothing About Me Without Me”:The Patient Perspective

    • Presenter

    • Prof. Erica Marsh(University of Michigan, Ann Arbor, MI, USA)

    • 14:00 – 14:18

    • New Perspectives on Treatment

    • Prof. Ayman Al-Hendy(University of Chicago, Chicago, IL, US)

    • Time

    • 14:00 – 14:18

    • Presentation Title

    • New Perspectives on Treatment

    • Presenter

    • Prof. Ayman Al-Hendy(University of Chicago, Chicago, IL, US)

    • 14:18 – 14:20

    • Closing Remarks andTake-Home Points

    • Prof. Kristina Gemzell-Danielsson

    • Time

    • 14:18 – 14:20

    • Presentation Title

    • Closing Remarks andTake-Home Points

    • Presenter

    • Prof. Kristina Gemzell-Danielsson

Faculty

Professor Kristina Gemzell-Danielsson

Professor Kristina Gemzell-Danielsson

Stockholm, Sweden

Welcome and Introduction – the 21st Century Perspective
● Introduction to speakers● Overall symposium theme and objectives

  • See biography

    Professor Kristina Gemzell-Danielsson, MD, PhD, is Head of the Department of Women’s and Children’s Health, Karolinska Institutet, Sweden, and senior consultant in Obstetrics and Gynaecology at the Karolinska University Hospital. She is Director of the WHO collaborating centre in Human Reproduction and Chair of the FIGO committee on Human Rights, refugees and violence against women.

Professor Erica Marsh

Professor Erica Marsh, MD MSCI FACOG

Michigan, USA

Nothing About Me Without Me: The Patient Perspective
Presentation learning objectives● Identify the common disconnect between patients and healthcare professionals● Learn how we can all become much more patient centred

  • See biography

    Erica E. Marsh, MD, MSCI, FACOG, is the S. Jan Behrman Collegiate Professor of Reproductive Medicine at the University of Michigan Medical School and Chief of the Division of Reproductive Endocrinology and Infertility in the Department of OBGYN. She is the Founder and Director of the Women’s Health and Reproductive Disparities Collaborative (onWHARD) and the Director of Community Engagement for the Michigan Institute for Clinical and Health Research at UM.
    Dr. Marsh graduated magna cum laude from Harvard College and cum laude from Harvard Medical School. She completed her residency at the Integrated OBGYN Residency at the Brigham and Women’s Hospital and Massachusetts General Hospital followed by an REI fellowship at Northwestern University. Dr. Marsh’s research focuses on developing a holistic understanding of fibroids, abnormal uterine bleeding, and ovarian reserve. Dr. Marsh is a committed community advocate, scientific mentor, and proponent of community-engaged research.

Professor Ayman Al-Hendy

Professor Ayman Al-Hendy

Chicago, USA

New Perspectives on Treatment
Presentation learning objectives● Understand the estrogen-driven basis of uterine fibroids● Review different therapeutic approaches to the management of uterine fibroids – including GnRH antagonists being developed

  • See biography

    Gynaecologist and Endoscopic Surgeon at the Department of Obstetrics and Gynecology, University of Chicago. Double board certified physician at (Canadian) Royal College of Surgeons and The American Board of Obstetrics and Gynaecology. Dr. Al-Hendy’s medical research interests focus on developing novel therapies, including gene and stem cell therapy, for premature ovarian insufficiency, endometriosis, and particularly uterine fibroids. He is currently researching the utility of various nutritional supplements as possible non-surgical therapy for uterine fibroids - which negatively impact women’s health worldwide and burden resources through the high rate of hysterectomy especially in women of colour.